A Neutral CB1 Antagonist Also Precipitated Withdrawal in Cannabinoid-Adapted Mice

Withdrawal-related behavior in cannabinoid-adapted mice was not confined to an inverse agonist. A centrally acting neutral antagonist also produced signs, challenging a simple explanation based entirely on inverse agonism.

The experiment used a potent synthetic agonist

Male mice received repeated AM2389, which produced pronounced cannabinoid-like effects and temperature tolerance. THC was used in selected comparisons and substitution experiments. AM2389 was the dependence-inducing compound; the experiment should not be described as a human cannabis-withdrawal trial.

Two ways of blocking signaling were compared

Rimonabant, an inverse agonist, and AM4113, a neutral antagonist, both produced withdrawal-related responses in adapted animals. Their patterns were not identical. The antagonist with limited brain penetration, AM6545, did not produce the same syndrome under the tested conditions.

A mechanistic inference, not a complete localization

The findings supported rapid competition at brain CB1 receptors as an explanation that did not require inverse agonism alone. The peripheral comparison strengthened that interpretation but did not prove that every peripheral receptor or exposure condition is irrelevant. Drug distribution, dose and measured signs remain part of the evidence.

Substitution did not establish a treatment plan

Reintroducing AM2389 or THC reversed precipitated signs in this model. That is evidence about receptor-mediated withdrawal expression, not a validated strategy for treating people. Small animal experiments and forced antagonist challenges differ from spontaneous withdrawal after ordinary cannabis use. The study clarifies a mechanism without establishing clinical efficacy, safety or an individual’s dependence severity.

Related analysis: Cannabis Tolerance Claims: Questions to Ask Before Relying on Expert Testimony.

Primary research

Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology (2015). DOI: 10.1007/s00213-015-3907-0.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Saliva Cannabis Detection Windows Change With THC AND Versus OR a Metabolite

Requiring both THC and its metabolite to exceed a cutoff can produce a different saliva detection window from accepting either compound. A controlled human cannabis-smoking study demonstrated that difference, particularly among occasional smokers. The result concerns how a test defines a positive sample; it does not establish how long a…

Spread the love

Read Article: Saliva Cannabis Detection Windows Change With THC AND Versus OR a Metabolite

A CB2 Knockout Experiment Did Not Test Whether Cannabis Causes Psychosis

A mouse experiment linked altered cannabinoid CB2 receptor function with methamphetamine-related behavioral responses. It did not administer cannabis or determine whether THC exposure caused a psychiatric disorder. The intervention was genetic receptor disruption Researchers studied mice with partial Cnr2 gene deletion and animals with deletion in a selected neuronal population….

Spread the love

Read Article: A CB2 Knockout Experiment Did Not Test Whether Cannabis Causes Psychosis

A Prenatal Alcohol Study Linked Exposure to Lifetime Cannabis Use, Not Earlier Initiation

A longitudinal study associated maternal alcohol dose per drinking occasion during pregnancy with greater reported lifetime cannabis use in young adulthood. It did not find the same association with every cannabis-use measure, including age at first use. Exposure preceded the later reports The analysis involved 121 young adults from the…

Spread the love

Read Article: A Prenatal Alcohol Study Linked Exposure to Lifetime Cannabis Use, Not Earlier Initiation

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us